放射外科治疗多发性硬化相关三叉神经痛:长期结局的回顾性综述
该回顾性综述评估了多发性硬化相关三叉神经痛(MS-TN)患者接受伽玛刀放射外科(GKRS)后长期面部疼痛与麻木的结局。42例患者中,初始GKRS后1、3、5、7年疼痛控制率分别为62%、29%、22%、13%;首次补救GKRS后分别为84%、50%、44%、17%。结论认为初始GKRS短期疼痛控制良好,但长期控制不常见;补救GKRS似乎能提供有益的疼痛控制且面部麻木困扰率低。
要点
- 初始GKRS后1年疼痛控制率为62%,7年降至13%。
- 首次补救GKRS后1年疼痛控制率为84%,7年为17%。
- 末次随访时83%患者达到疼痛控制,10%有BNI IV级面部麻木。
核心结论
- 初始GKRS对MS-TN提供良好的短期疼痛控制,但长期疼痛控制不常见。
- 若初始GKRS失败,补救GKRS似乎能提供有益的疼痛控制,且令人困扰的面部麻木发生率低。
研究设计与样本
- 回顾性综述,纳入1998年至2014年因MS-TN接受GKRS且随访至少3年的患者,共42例回应调查(31例女性[74%],中位年龄59岁,范围32-76岁)。
主要发现
- 初始GKRS(n=42)后1、3、5、7年疼痛控制率分别为62%、29%、22%、13%。
- 首次补救GKRS(n=25)后1、3、5、7年疼痛控制率分别为84%、50%、44%、17%。
- 初始GKRS联合或不联合1次补救GKRS(n=33)后1、3、5、7、10年疼痛控制率分别为92%、72%、52%、46%、17%。
- 28例(67%)接受补救治疗,其中25例(60%)首次补救为GKRS。
- 末次随访时,42例中9例(21%)为BNI I级面部疼痛,35例(83%)达到疼痛控制,4例(10%)为BNI IV级面部麻木(日常生活非常困扰)。
关键数值与推荐
- 疼痛控制定义为Barrow神经病学研究所(BNI)面部疼痛强度量表I-IIIb级。
- 初始GKRS靶点为三叉神经根进入区,单等中心,4-mm准直器,90%等剂量线完全覆盖三叉神经,50%等剂量线紧贴脑干表面。
- 中位最大放射剂量为85 Gy(范围50-85 Gy),中位随访78个月(范围36-226个月)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to assess long-term outcomes of facial pain and numbness after radiosurgery for multiple sclerosis (MS)-related trigeminal neuralgia (MS-TN). METHODS: The authors conducted a retrospective review of their Gamma Knife radiosurgeries (GKRSs) to identify all patients treated for MS-TN (1998-2014) with at least 3 years of follow-up. Treatment and clinical data were obtained via chart review and mailed or telephone surveys. Pain control was defined as a facial pain score of I-IIIb on the Barrow Neurological Institute (BNI) Facial Pain Intensity Scale. Kaplan-Meier analysis was performed to determine the rates of pain control after index and first salvage GKRS procedures. Patients could have had more than 1 salvage procedure. Pain control rates were based on the number of patients at risk during follow-up. RESULTS: Of the 50 living patients who underwent GKRS, 42 responded to surveys (31 women [74%], median age 59 years, range 32-76 years). During the initial GKRS, the trigeminal nerve root entry zone was targeted with a single isocenter, using a 4-mm collimator with the 90% isodose line completely covering the trigeminal nerve and the 50% isodose line abutting the surface of the brainstem. The median maximum radiation dose was 85 Gy (range 50-85 Gy). The median follow-up period was 78 months (range 36-226 months). The rate of pain control after the index GKRS (n = 42) was 62%, 29%, 22%, and 13% at 1, 3, 5, and 7 years, respectively. Twenty-eight patients (67%) underwent salvage treatment, including 25 (60%) whose first salvage treatment was GKRS. The rate of pain control after the first salvage GKRS (n = 25) was 84%, 50%, 44%, and 17% at 1, 3, 5, and 7 years, respectively. The rate of pain control after the index GKRS with or without 1 salvage GKRS (n = 33) was 92%, 72%, 52%, 46%, and 17% at 1, 3, 5, 7, and 10 years, respectively. At last follow-up, 9 (21%) of the 42 patients had BNI grade I facial pain, 35 (83%) had achieved pain control, and 4 (10%) had BNI grade IV facial numbness (very bothersome in daily life). CONCLUSIONS: Index GKRS offers good short-term pain control for MS-TN, but long-term pain control is uncommon. If the index GKRS fails, salvage GKRS appears to offer beneficial pain control with low rates of bothersome facial numbness.
引用
- Przybylowski CJ, Cole TS, Baranoski JF, et al. Radiosurgery for multiple sclerosis-related trigeminal neuralgia: retrospective review of long-term outcomes. J Neurosurg. 2018. PMID: 30544359. doi:10.3171/2018.5.JNS173194
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。